Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Belenos
Delaware, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Belenos has not disclosed clinical trial results yet; a planned Phase 1 study of CM512 in asthma is in preparation.
- Therapeutic areas
- ImmunologyPulmonology
- Modalities
- Bispecific monoclonal antibody
- Industry
- Biotech
02
Partnerships
Keymed Biosciences (licensed drug candidates CM512 and CM536)iBridge HK (received equity interest as part of licensing deal)
Beyond the preview
Go deeper on Belenos.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Belenos.